|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.
The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on August 27, 2020. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 98.41% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $2.52 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Outlook Therapeutics.
There is no upcoming split for Outlook Therapeutics.
Outlook Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.